Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial

Published:2012-02-16 Issue:7 Volume:33 Page:857-865
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Lüscher Thomas F.,Taddei Stefano,Kaski Juan-Carlos,Jukema J. Wouter,Kallend David,Münzel Thomas,Kastelein John J.P.,Deanfield John E.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/33/7/857/17894255/ehs019.pdf

Reference53 articles.

1. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study;Sharrett;Circulation,2001

2. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis;Law;BMJ,2003

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

4. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events;Barter;N Engl J Med,2007

5. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia;Le Goff;Pharmacol Ther,2004

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

2. Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis;Journal of Cardiovascular Development and Disease;2024-05-16

3. Evolving Therapeutic Targets;Clinical Lipidology;2024

4. Imaging Biomarkers: Flow-Mediated Dilation as Predictor in Cardiovascular Disease;Early Vascular Aging (EVA);2024

5. Association of HDL-Cholesterol, hypertension and left ventricular hypertrophy in youths with overweight or obesity;Nutrition, Metabolism and Cardiovascular Diseases;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3